{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:39:10Z","timestamp":1759333150424,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) are the two most prevalent autoantibodies in rheumatoid arthritis (RA), and are thought to have distinct autoantigen targets. Whilst RF targets the Fc region of antibodies, ACPAs target a far broader spectrum of citrullinated peptides. Here we demonstrate significant sequence and structural homology between proposed RF target epitopes in IgG1 Fc and the ACPA target fibrinogen. Two of the three homologous sequences were susceptible to citrullination, and this modification, which occurs extensively in RA, permitted significant cross-reactivity of RF+ patient sera with fibrinogen in both western blots and ELISAs. Crucially, this reactivity was specific to RF as it was absent in RF\u2212 patient and healthy control sera, and could be inhibited by pre-incubation with IgG1 Fc. These studies establish fibrinogen as a common target for both RF and ACPAs, and suggest a new mechanism in RF-mediated autoimmune diseases wherein RF may act as a precursor from which the ACPA response evolves.<\/jats:p>","DOI":"10.1038\/s41598-019-48176-3","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T10:04:06Z","timestamp":1566209046000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Citrullination facilitates cross-reactivity of rheumatoid factor with non-IgG1 Fc epitopes in rheumatoid arthritis"],"prefix":"10.1038","volume":"9","author":[{"given":"Malgorzata","family":"Trela","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shantha","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Sheeran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Rylance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4521-9009","authenticated-orcid":false,"given":"Kesley","family":"Attridge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"48176_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1155\/2013\/726598","volume":"35","author":"F Ingegnoli","year":"2013","unstructured":"Ingegnoli, F., Castelli, R. & Gualtierotti, R. Rheumatoid factors: clinical applications. Dis. Markers. 35, 727\u2013734 (2013).","journal-title":"Dis. Markers."},{"key":"48176_CR2","first-page":"33","volume":"1","author":"OMR Westwood","year":"2008","unstructured":"Westwood, O. M. R. et al. Comparison of antigenic regions identified on IgG1Fc using bioinformatics vs pepscan analysis. Clin. Med. Arthritis Musculoskelet. Disord. 1, 33\u201342 (2008).","journal-title":"Clin. Med. Arthritis Musculoskelet. Disord."},{"key":"48176_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/rheumatology\/kei228","volume":"45","author":"OMR Westwood","year":"2006","unstructured":"Westwood, O. M. R., Nelson, P. N. & Hay, F. C. Rheumatoid factors: what\u2019s new? Rheumatology (Oxford). 45, 379\u2013385 (2006).","journal-title":"Rheumatology (Oxford)."},{"key":"48176_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1186\/s13075-015-0666-6","volume":"17","author":"C Fernandes-Cerqueira","year":"2015","unstructured":"Fernandes-Cerqueira, C. et al. Targeting of anti-citrullinated protein\/peptide antibodies in rheumatoid arthritis using peptides mimicking endogenously citrullinated fibrinogen antigens. Arthritis Res. Ther. 17, 155 (2015).","journal-title":"Arthritis Res. Ther."},{"key":"48176_CR5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","volume":"14","author":"G Valesini","year":"2015","unstructured":"Valesini, G. et al. Citrullination and autoimmunity. Autoimmun. Rev. 14, 490\u2013497 (2015).","journal-title":"Autoimmun. Rev."},{"key":"48176_CR6","first-page":"44","volume":"3","author":"MA Badillo-Soto","year":"2016","unstructured":"Badillo-Soto, M. A. et al. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning. Eur. J. Rheumatol. 3, 44\u201349 (2016).","journal-title":"Eur. J. Rheumatol."},{"key":"48176_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","volume":"233","author":"N Wegner","year":"2010","unstructured":"Wegner, N. et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol. Rev. 233, 34\u201354 (2010).","journal-title":"Immunol. Rev."},{"key":"48176_CR8","doi-asserted-by":"publisher","first-page":"ii132","DOI":"10.1136\/annrheumdis-2012-202349","volume":"72","author":"LA Trouw","year":"2013","unstructured":"Trouw, L. A., Huizinga, T. W. J. & Toes, R. E. M. Autoimmunity in rheumatoid arthritis: different antigens\u2014common principles. Ann. Rheum. Dis. 72, ii132\u2013ii136 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"48176_CR9","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.autrev.2013.08.002","volume":"12","author":"F Pratesi","year":"2013","unstructured":"Pratesi, F. et al. HLA shared epitope and ACPA: Just a marker or an active player? Autoimmun. Rev. 12, 1182\u20131187 (2013).","journal-title":"Autoimmun. Rev."},{"key":"48176_CR10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/annrheumdis-2012-202726","volume":"73","author":"AM Quirke","year":"2014","unstructured":"Quirke, A. M. et al. Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis. Ann. Rheum. Dis. 73, 263\u2013269 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"48176_CR11","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00296-014-2956-8","volume":"34","author":"R Perez-Alamino","year":"2014","unstructured":"Perez-Alamino, R., Garcia-Valladares, I., Cuchacovich, R., Iglesias-Gamarra, A. & Espinoza, L. R. Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease? Rheumatol. Int. 34, 1211\u20131216 (2014).","journal-title":"Rheumatol. Int."},{"key":"48176_CR12","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.23514","volume":"58","author":"P Kakumanu","year":"2008","unstructured":"Kakumanu, P. et al. Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide. Arthritis Rheum. 58, 1576\u20131581 (2008).","journal-title":"Arthritis Rheum."},{"key":"48176_CR13","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1002\/eji.200535790","volume":"36","author":"M Sebbag","year":"2006","unstructured":"Sebbag, M. et al. Epitopes of human fibrin recognized by the rheumatoid arthritis-specific autoantibodies to citrullinated proteins. Eur. J. Immunol. 36, 2250\u20132263 (2006).","journal-title":"Eur. J. Immunol."},{"key":"48176_CR14","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1186\/ar3840","volume":"14","author":"R Raijmakers","year":"2012","unstructured":"Raijmakers, R. et al. Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res. Ther. 14, R114 (2012).","journal-title":"Arthritis Res. Ther."},{"key":"48176_CR15","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1136\/annrheumdis-2012-202868","volume":"73","author":"M Cornillet","year":"2014","unstructured":"Cornillet, M. et al. The fibrin-derived citrullinated peptide \u03b260\u201374Cit 60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies. Ann. Rheum. Dis. 73, 1246\u20131252 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"48176_CR16","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13075-016-1181-0","volume":"18","author":"V Joshua","year":"2016","unstructured":"Joshua, V. et al. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells. Arthritis Res. Ther. 18, 284 (2016).","journal-title":"Arthritis Res. Ther."},{"key":"48176_CR17","doi-asserted-by":"publisher","first-page":"E10169","DOI":"10.1073\/pnas.1713112114","volume":"114","author":"F Arnoux","year":"2017","unstructured":"Arnoux, F. et al. Peptidyl arginine deiminase immunization induces anticitrullinated protein antibodies in mice with particular MHC types. Proc. Natl. Acad. Sci. 114, E10169\u2013E10177 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"48176_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0165-2478(03)00056-7","volume":"88","author":"PN Nelson","year":"2003","unstructured":"Nelson, P. N. et al. Characterisation of epitopes of pan-IgG\/anti-G3m(u) and anti-Fc monoclonal antibodies. Immunol. Lett. 88, 77\u201383 (2003).","journal-title":"Immunol. Lett."},{"key":"48176_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","volume":"171","author":"JA Hill","year":"2003","unstructured":"Hill, J. A. et al. Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule. J. Immunol. 171, 538\u2013541 (2003).","journal-title":"J. Immunol."},{"key":"48176_CR20","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1084\/jem.20160792","volume":"10","author":"EM Tan","year":"2016","unstructured":"Tan, E. M. & Smolen, J. S. Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J. Exp. Med. 10, 1937\u20131950 (2016).","journal-title":"J. Exp. Med."},{"key":"48176_CR21","first-page":"2359","volume":"28","author":"AT Masi","year":"2001","unstructured":"Masi, A. T., Aldag, J. C. & Sipes, J. Do elevated levels of serum C-reactive protein predict rheumatoid arthritis in men: correlations with pre-RA status and baseline positive rheumatoid factors. J. Rheumatol. 28, 2359\u20132361 (2001).","journal-title":"J. Rheumatol."},{"key":"48176_CR22","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantap\u00e4\u00e4-Dahlqvist","year":"2003","unstructured":"Rantap\u00e4\u00e4-Dahlqvist, S. et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 48, 2741\u20132749 (2003).","journal-title":"Arthritis Rheum."},{"key":"48176_CR23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/art.20018","volume":"50","author":"MMJ Nielen","year":"2004","unstructured":"Nielen, M. M. J. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis Rheum. 50, 380\u2013386 (2004).","journal-title":"Arthritis Rheum."},{"key":"48176_CR24","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/ar1868","volume":"8","author":"M Johansson","year":"2006","unstructured":"Johansson, M., \u00c4rlestig, L., Hallmans, G. & Rantap\u00e4\u00e4-Dahlqvist, S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res. Ther. 8, R19 (2006).","journal-title":"Arthritis Res. Ther."},{"key":"48176_CR25","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1136\/ard.2007.073825","volume":"67","author":"KT Jorgensen","year":"2008","unstructured":"Jorgensen, K. T. et al. Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann. Rheum. Dis. 67, 860\u2013866 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"48176_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/art.37835","volume":"65","author":"M Brink","year":"2013","unstructured":"Brink, M. et al. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis. Arthritis Rheum. 65, 899\u2013910 (2013).","journal-title":"Arthritis Rheum."},{"key":"48176_CR27","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/j.1399-3011.1990.tb00973.x","volume":"36","author":"E T\u0171d\u0151s","year":"1990","unstructured":"T\u0171d\u0151s, E., Cserz\u0151, M. & Simon, I. Predicting isomorphic residue replacements for protein design. Int. J. Pept. Protein Res. 36, 236\u2013239 (1990).","journal-title":"Int. J. Pept. Protein Res."},{"key":"48176_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-014-0370-6","volume":"15","author":"A Warnecke","year":"2014","unstructured":"Warnecke, A., Sandalova, T., Achour, A. & Harris, R. A. PyTMs: a useful PyMOL plugin for modeling common post-translational modifications. BMC Bioinformatics. 15, 370 (2014).","journal-title":"BMC Bioinformatics."},{"key":"48176_CR29","doi-asserted-by":"publisher","first-page":"17015","DOI":"10.1021\/ja308871v","volume":"134","author":"KL Bicker","year":"2012","unstructured":"Bicker, K. L., Subramanian, V., Chumanevich, A. A., Hofseth, L. J. & Thompson, P. R. Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. J. Am. Chem. Soc. 134, 17015\u201317018 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"48176_CR30","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.3899\/jrheum.130502","volume":"41","author":"PN Nelson","year":"2014","unstructured":"Nelson, P. N. et al. Rheumatoid arthritis is associated with IgG antibodies to human endogenous retrovirus Gag matrix: A potential pathogenic mechanism of disease? J. Rheumatol. 41, 1952\u20131960 (2014).","journal-title":"J. Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48176-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T12:42:28Z","timestamp":1671280948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48176-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48176"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48176-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12068"}}